Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Morris

Showing results (221-230 of 324) with videos related to

Pageof 33
Sort By:
Journal of Virology|November 3, 2021
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating AntibodiesDieter Mielke, Sherry Stanfield-Oakley, Bhavesh Borate, et al.
Scientific Reports|April 12, 2020
Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modificationsAdvaita Acarya Singh, Ofentse Pooe, Lusisizwe Kwezi, et al.
Frontiers in Immunology|April 11, 2022
Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant CouplesMelinda S Suchard, Neil Martinson, Susan Malfeld, et al.
Journal of Virology|May 27, 2011
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individualElin S Gray, M Anthony Moody, Constantinos Kurt Wibmer, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
American Journal of Human Genetics|March 4, 2008
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 geneNancy D Merner, Kathy A Hodgkinson, Annika F M Haywood, et al.
Frontiers in Immunology|September 28, 2018
High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not AdultsJulia Roider, Takashi Maehara, Abigail Ngoepe, et al.
Frontiers in Immunology|January 11, 2020
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape PathwayDieter Mielke, Gama Bandawe, Justin Pollara, et al.
Cell Host & Microbe|June 5, 2018
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 InfectionIan Setliff, Wyatt J McDonnell, Nagarajan Raju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2015
Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoireCathrine Scheepers, Ram K Shrestha, Bronwen E Lambson, et al.
Pageof 33

Showing results (221-230 of 324) with videos related to

Sort By:
Pageof 33
Journal of Virology|November 3, 2021
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating AntibodiesDieter Mielke, Sherry Stanfield-Oakley, Bhavesh Borate, et al.
Scientific Reports|April 12, 2020
Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modificationsAdvaita Acarya Singh, Ofentse Pooe, Lusisizwe Kwezi, et al.
Frontiers in Immunology|April 11, 2022
Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant CouplesMelinda S Suchard, Neil Martinson, Susan Malfeld, et al.
Journal of Virology|May 27, 2011
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individualElin S Gray, M Anthony Moody, Constantinos Kurt Wibmer, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
American Journal of Human Genetics|March 4, 2008
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 geneNancy D Merner, Kathy A Hodgkinson, Annika F M Haywood, et al.
Frontiers in Immunology|September 28, 2018
High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not AdultsJulia Roider, Takashi Maehara, Abigail Ngoepe, et al.
Frontiers in Immunology|January 11, 2020
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape PathwayDieter Mielke, Gama Bandawe, Justin Pollara, et al.
Cell Host & Microbe|June 5, 2018
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 InfectionIan Setliff, Wyatt J McDonnell, Nagarajan Raju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2015
Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoireCathrine Scheepers, Ram K Shrestha, Bronwen E Lambson, et al.
Pageof 33